Meteospasmyl 30 capsules — Made in France — Free Delivery

Product description

Meteospasmyl is prescribed for the symptomatic treatment of functional intestinal disorders, especially those manifested by flatulence.

Compound

active ingredients: 1 capsule contains alverin citrate 60 mg simethicone 300 mg. Excipients: gelatin, glycerin, titanium dioxide (E 171).

Alverin is a myotropic antispasmodic. Simethicone is a physiologically inert substance with no pharmacological activity. It breaks the surface tension of the air bubbles, which facilitates their union.

Contraindications

Hypersensitivity to alverin or any other component of the preparation. Intestinal obstruction, including paralytic; obstructive diseases of the gastrointestinal tract.

Application features

Use during pregnancy or lactation

Pregnancy

Simethicone: due to negligible systemic exposure of simethicone, a negative effect when used during pregnancy is not expected.

Alverin: There are no comprehensive data on teratogenicity in animals. To date, no clinical effects such as malformations or fetotoxic effects have been reported. However, monitoring alverin exposure during pregnancy is not sufficient to rule out any risk.

Thus, it is not recommended to use the preparation Meteospasmyl during pregnancy.

Lactation

Due to the negligible systemic exposure of simethicone, a negative effect when used during breastfeeding is not expected.

There are no data on the excretion of alverin in breast milk.

Therefore, it is not recommended to use the preparation Meteospasmyl during breastfeeding.

Children

The preparation is used in pediatric practice.

The ability to influence the reaction rate when driving or driving other mechanisms

Meteospasmyl has an insignificant effect on the ability to drive vehicles or other mechanisms. Adverse reactions such as dizziness have been reported in some patients. These types of disorders can affect the ability to drive vehicles or other mechanisms.

Method of administration and dosage

For adults, use 1 capsule 2-3 times a day before meals or for pain.

The course of treatment is determined by the doctor individually.

Overdose

When using doses higher than recommended, cases of dizziness have been reported.

Adverse Reactions

The following adverse reactions were reported with the following frequency: very often (≥ 1/10), often (≥ 1/100 and <1/10), infrequently (≥ 1/1000 and <1/100), rarely (≥ 1 / 10,000 and <1/1000), very rare (<1/10000), and frequency unknown (cannot be estimated from available data).

From the side of the nervous system: the frequency is unknown - headache.

From the immune system: very rarely - anaphylactoid reactions, anaphylactic shock.

On the part of the hearing and labyrinth organs: the frequency is unknown - dizziness.

From the liver and biliary tract: very rarely - cytolytic hepatitis (see section "Peculiarities of use").

From the gastrointestinal tract: frequency unknown - nausea.

On the part of the skin and subcutaneous tissues: the frequency is unknown - angioedema, rash, urticaria and itching.

Storage conditions

Store at a temperature not exceeding 25 ° C, out of the reach of children.

Shelf life is 3 years.